VOR

8.305

2.41% -0.205

Pre-mercato: 8.28 -0.025 -0.30%

Vor Biopharma Inc (VOR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$8.51

Aprire:

$8.41

Volume 24 ore:

387.00K

Relative Volume:

0.64

Capitalizzazione di mercato:

$181.97M

Reddito:

Utile/perdita netta:

$-112.46M

Rapporto P/E:

-5.064

EPS:

-1.64

Flusso di cassa netto:

$-99.89M

1 W Prestazione:

+4.47%

1M Prestazione:

-59.61%

6M Prestazione:

+81.57%

1 anno Prestazione:

-53.57%

Intervallo 1D:

$8.03

$8.49

Intervallo di 1 settimana:

$7.21

$8.66

Portata 52W:

$2.622

$65.80

Vor Biopharma Inc Stock (VOR) Company Profile

Nome

Vor Biopharma Inc

Settore

Healthcare (1131)

Industria

Biotechnology (632)

Telefono

617-655-6580

Indirizzo

500 BOYLSTON STREET, BOSTON

Dipendente

168

Cinguettio

Prossima data di guadagno

2024-11-05

Ultimi documenti SEC

VOR's Discussions on Twitter

Confronta VOR con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
VOR Vor Biopharma Inc	8.305	186.46M	0	-112.46M	-99.89M	-1.64
VRTX Vertex Pharmaceuticals Inc	457.26	117.50B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	722.83	76.06B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	464.56	62.53B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	916.31	56.75B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	205.04	44.10B	447.02M	-1.18B	-906.14M	-6.1812

Vor Biopharma Inc Stock (VOR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-11-25	Ripresa	Wedbush	Neutral
2025-10-15	Aggiornamento	Robert W. Baird	Neutral → Outperform
2025-09-24	Aggiornamento	Stifel	Hold → Buy
2025-06-30	Aggiornamento	H.C. Wainwright	Neutral → Buy
2022-07-26	Iniziato	Wedbush	Outperform
2022-04-27	Iniziato	Goldman	Neutral
2021-12-17	Iniziato	H.C. Wainwright	Buy
2021-12-03	Iniziato	Robert W. Baird	Outperform
2021-12-02	Iniziato	Oppenheimer	Outperform
2021-10-19	Iniziato	JMP Securities	Mkt Outperform
2021-03-25	Iniziato	B. Riley Securities	Buy
2021-03-03	Iniziato	Barclays	Overweight
2021-03-03	Iniziato	Evercore ISI	Outperform
2021-03-02	Iniziato	Goldman	Sell
2021-03-02	Iniziato	Stifel	Buy

Mostra tutto

Vor Biopharma Inc Borsa (VOR) Ultime notizie

Dec 03, 2025

Will Vor Biopharma Inc. stock maintain momentum in 2025Gold Moves & Capital Efficiency Focused Strategies - Newser

Dec 03, 2025

What drives Vor Biopharma Inc stock priceEarnings Surprise Analysis & Superior Capital Trading Plans - earlytimes.in

Dec 03, 2025

Dec 02, 2025

Is There An Opportunity With Vor Biopharma Inc.'s (NASDAQ:VOR) 49% Undervaluation? - Yahoo Finance

Dec 02, 2025

Vor Biopharma Inc. (NASDAQ:VOR) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat

Dec 02, 2025

Dec 01, 2025

Form 424B3 Vor Biopharma Inc. - StreetInsider

Dec 01, 2025

Nov 28, 2025

Wedbush Predicts Vor Biopharma's Q4 Earnings (NASDAQ:VOR) - MarketBeat

Nov 28, 2025

Nov 26, 2025

How Vor Biopharma Inc. stock benefits from global expansionLayoff News & Fast Exit and Entry Strategy Plans - BỘ NỘI VỤ

Nov 26, 2025

Wedbush Begins Coverage on Vor Biopharma (NASDAQ:VOR) - MarketBeat

Nov 26, 2025

Nov 25, 2025

Vor Biopharma (VOR) Upgraded to Buy: Here's What You Should Know - sharewise.com

Nov 25, 2025

Wedbush Initiates Coverage on Vor Biopharma (VOR) with Neutral R - GuruFocus

Nov 25, 2025

Wedbush Boosts Price Target on Vor Biopharma to $9 From $0.40, Keeps Neutral Rating - MarketScreener

Nov 25, 2025

Wedbush Assumes Vor Biopharma, Inc. (VOR) at Neutral - StreetInsider

Nov 25, 2025

Nov 21, 2025